BSD reveals Japanese distribution partner:
This article was originally published in Clinica
Executive Summary
BSD Medical is to see its precision-focused RF/microwave cancer treatment debut in Japan after enlisting Tokyo-based Ktec as its distributor for that market. Terms of the agreement were not disclosed. The deal marks the end of Salt Lake City, Utah-based BSD's "lengthy" search and negotiation process for a sales partner in the world's second largest medical device market. BSD is pursuing a global strategy to establish a chain of distributors in the Pacific Rim. The agreement with Ktec follows on from the recent appointment of Chinese firm Dalien Orientech as BSD's distributor in China.
You may also be interested in...
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip